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Summary 
Hormones encoded by the ghrelin gene, GHRL, regulate many body systems. Here, 
we show that GHRL is abundant in monocytes. Analysis of women subjected to 
bariatric surgery revealed a significant postoperative reduction of GHRL in 
monocytes. We hypothesise that GHRL mediates monocyte-adipocyte cross-talk in 
health and obesity. 
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1. Introduction 
Ghrelin is a pleiotropic hormone, with roles in appetite stimulation and energy 
balance (Gahete et al., 2014a). The ghrelin gene, GHRL, is predominately expressed 
in the stomach, and transcribed at lower levels in multiple cell types (Gahete et al., 
2014a). Our laboratory has a long-standing interest in characterising the structure, 
expression and function of peptide hormones derived from GHRL (Seim et al., 2013; 
Seim et al., 2016a). In this study, we initially assessed the expression of GHRL in 35 
cell or tissue types by interrogating publicly available RNA-seq data. 
 
2. Material and methods 
2.1 Gene expression data processing 
RNA-sequencing data, from 35 human adult somatic tissue or cell types (each with a 
minimum of three biological replicates), were obtained from the Human Protein Atlas 
(Uhlen et al., 2015) and ENCODE (Dunham et al., 2012) consortia and interrogated 
for ghrelin gene (GHRL) expression. For sample details see Seim et al., 2016b. To 
further investigate GHRL expression in monocytes, we examined an RNA-seq data 
set from 19 women before and three months after bariatric surgery, each with two 
technical replicates (NCBI GEO: GSE66306). FASTQ files were aligned to the 
human genome (hg19) using TopHat (v2.0.9) (Kim et al., 2013). Gene counts were 
computed by featureCounts v1.4.5-p1 (Liao et al., 2014) and normalised using the 
quantile method (R package ‘preprocessCore’). A paired Student's t-test was used for 
two-group comparisons, with P ≤ 0.05 considered significant.  
 
2.2. GHRL expression in THP-1 cells treated with interferon- γ 
The human acute monocytic leukaemia cell line THP-1 (ATCC TIB-202) was treated 
with interferon-γ (IFN-γ) (50 ng/ml; R&D Systems) or vehicle (PBS) for 24 hrs. RNA 
was extracted (High Pure RNA Isolation kit, Roche), cDNA generated (iScript; Bio-
Rad), and qRT-PCR (2X SYBR green) performed using an AB7500 Fast thermal 
cycler (Applied Biosystems). GHRL qRT-PCR was performed (assay cat. no. 
QT00041377; QIAGEN) and normalised to the housekeeping gene TATA box protein 
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(TBP) (5'-TCGCTTCCGCTGGCCCATAGT-3’ and 5'-
TCTCCAGCACACTCTTCTCAGCAA-3’). The relative expression of GHRL was 
calculated using the comparative 2-∆∆Ct method. IFN-γ treated and control groups 
were compared using the Mann-Whitney U test (P ≤ 0.05 considered significant). 
 
3. Results and discussion 
Surprisingly, GHRL expression was relatively abundant in monocytes and lymphoid 
tissues, such as bone marrow and lymph nodes (Fig. 1A). An assessment of exon 
coverage in monocytes confirmed expression of canonical preproghrelin coding exons 
1 to 4 (Fig. 1B), as described for peripheral blood mononuclear cells (Dixit et al., 
2004; Gahete et al., 2014b).  
As the function of GHRL in immune cells and its relationship with disease has 
hitherto remained enigmatic, we examined transcriptomes of 19 women before and 
three months after bariatric surgery (Poitou et al., 2015). Our analysis revealed 
significantly reduced GHRL expression in monocytes after surgery (P = 0.0001) (Fig. 
1C and Table 1), but no difference in adipocytes from the same cohort (data not 
shown). Serum and enteroendocrine ghrelin production are reduced in most patients 
following bariatric procedures (Meek et al., 2015), and we now demonstrate that 
monocyte GHRL expression is also modulated. 
Reduced GHRL expression in monocytes postoperatively may result from 
altered expression or signalling of GHRL-regulating molecules (e.g. leptin and 
cytokines), or from improved glucose homeostasis. In blood and tissues, the pro-
inflammatory cytokine interferon-γ (IFN-γ) is elevated in obesity and reduced 
following bariatric surgery (Zhang et al., 2011; Monteiro-Sepulveda et al., 2015), and 
there is evidence that IFN-γ may regulate GHRL expression. GHRL expression was 
significantly decreased in human THP-1 monocytic leukemia cells treated with IFN-γ 
(Fig. 1D; P = 0.0079), suggesting that IFN-γ signalling can potently modulate GHRL 
expression in this monocyte-derived cell line. Indeed, the bariatric surgery cohort 
examined here showed evidence of a distinct IFN-γ signalling pathway in adipose 
tissue and monocytes postoperatively (Poitou et al., 2015). IFN-γ represses gastric 
GHRL expression in non-obese mice infected with Helicobacter pylori (Strickertsson 
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et al., 2011) and IFN-γ regulation has also been associated with dietary interventions 
in rodents (Lee et al., 2006; Poitou et al., 2015). Taken together, we speculate that 
weight reduction modulates the expression of GHRL via an altered IFN-γ signalling 
pathway. 
What are the consequences of reduced monocyte GHRL expression after 
bariatric surgery? Obesity induces inflammation in adipose tissue, and metabolic 
improvements after bariatric surgery are mediated by the reversal of endocrine and 
immune responses associated with ‘pathogenic’ adipose tissue. A very recent study 
demonstrated that inflamed adipose tissue directly stimulates aberrant monocyte 
production in the bone marrow (monocytosis) to further exacerbate obesity-associated 
disease processes (Nagareddy et al., 2014). The GHRL derived peptide hormones 
ghrelin and obestatin regulate adiposity and may promote associated inflammation in 
adipose tissue (Tsubone et al., 2005; Rodriguez et al., 2009; Gurriaran-Rodriguez et 
al., 2011). We hypothesise that obesity-associated monocytosis and inflammation, 
coupled with the action of monocyte-derived paracrine GHRL-derived hormones on 
adipocytes, regulates metabolism and adipogenesis. Conversely, reduced monocyte 
GHRL expression following bariatric surgery may improve adipose tissue function.   
Monocyte GHRL expression was reduced in ~60% of subjects 12 weeks 
postoperatively, while expression was not altered in the remainder (Table 1). 
Importantly, the patients were still markedly obese (Poitou et al., 2015). It would be 
of interest in future studies to examine whether monocyte GHRL expression is 
reduced for longer than three months after surgery and correlates with successful 
longer-term bariatric surgery outcomes. In addition, it would be useful to examine the 
expression of monocyte GHRL in other obesity-associated pathologies, such as 
Prader-Willi syndrome (where patients exhibit hyperghrelinaemia and hyperphagia 
from an early age) and metabolic syndrome in general (a risk factor for cancer). Our 
study demonstrates the power of mining public genome-wide gene expression data 
and provides further impetus into the study of cross-talk between the endocrine and 
immune systems and the ghrelin axis. 
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Figure captions 
Figure 1. A. A box plot reveals high GHRL expression in monocytes and associated 
tissues (red dots). From the Human Protein Atlas: adipose tissue, adrenal gland, 
appendix, bone marrow, cerebral cortex, colon, duodenum, endometrium, 
oesophagus, gall bladder, kidney, liver, lung, lymph node, ovary, pancreas, placenta, 
prostate, rectum, salivary gland, skeletal muscle, skin, small intestine, smooth muscle, 
spleen, stomach, testis, thyroid gland, tonsil, urinary bladder, and uterine tube. From 
ENCODE: keratinocytes, (CD4+) monocytes, and osteoblasts. B. Integrative 
Genomics Viewer (IGV) visualisation of the GHRL locus in monocytes validates 
expression of all canonical preproghrelin-coding exons. C. Monocyte GHRL 
expression is reduced 3 months after bariatric surgery. Mean ± S.E.M. P value, 
Student’s t-test. D. GHRL expression (qRT-PCR) in human THP-1 monocytic 
leukemia cells treated with 50 ng/ml interferon-γ (IFN-γ) for 24 h (n=6 per group), 
compared to untreated controls. Mean ± S.E.M. ** P ≤ 0.01, Mann–Whitney U test.  
 
Tables 
Table 1. Monocyte GHRL expression shifts three months after bariatric surgery. 
Quantile normalised gene counts are shown (mean ± S.E.M., n=2). ↓denotes 
decreased GHRL expression. A dash (-) indicates no change in gene expression. 
Patients (PM) underwent adjustable gastric banding (AGB) or Roux-en-Y gastric 
bypass surgery (RYGB). 
Patient 
ID 
Type of 
surgery 
Normalised GHRL gene count Direction of 
expression 
change Before After 
mean S.E.M mean S.E.M 
PM01 AGB 58.2 3.1 39.1 3.6 ↓ 
PM02 RYGB 28.7 5.3 34.7 6.8 - 
PM05 RYGB 63.4 4.3 41.1 3.2 ↓ 
PM06 RYGB 73.3 12.7 48.9 1.4 ↓ 
PM08 RYGB 38.6 5.2 28.4 2.6 ↓ 
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PM09 AGB 54.3 2.8 28.6 1.4 ↓ 
PM10 RYGB 60.1 4.1 38.2 1.2 ↓ 
PM11 RYGB 60.8 0.0 36.8 2.7 ↓ 
PM12 RYGB 30.0 2.9 26.9 0.7 - 
PM13 AGB 71.0 1.8 51.0 6.1 ↓ 
PM15 RYGB 74.7 3.3 61.5 7.8 ↓ 
PM16 AGB 36.6 0.6 34.9 0.4 ↓ 
PM17 RYGB 44.8 7.5 51.8 1.5 - 
PM18 AGB 40.2 6.7 27.5 5.0 ↓ 
PM19 RYGB 32.7 5.1 35.6 2.9 - 
PM20 AGB 49.8 2.1 52.2 2.8 - 
PM21 AGB 102.8 2.6 44.6 7.6 ↓ 
PM22 RYGB 47.0 7.3 53.5 0.3 - 
PM23 AGB 49.5 5.8 54.0 1.0 - 
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